Dose–response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B.

MLA

Zhang, Chi, et al. “Dose–response Relationship between Serum N-Glycan Markers and Liver Fibrosis in Chronic Hepatitis B.” Hepatology International, vol. 18, no. 5, Oct. 2024, pp. 1434–47. EBSCOhost, https://doi.org/10.1007/s12072-024-10709-y.

APA

Zhang, C., Liu, Y., Wang, L., Liu, X., Chen, C., Zhang, J., Zhang, C., Wang, G., Zhuang, H., Zhao, H., Cao, L.-H., Zhang, Z.-Q., Zhao, W.-F., Shang, Q.-H., Zhang, D.-Z., Ma, A.-L., Xie, Q., Gui, H.-L., Zhang, G., & Liu, Y.-X. (2024). Dose–response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B. Hepatology International, 18(5), 1434–1447. https://doi.org/10.1007/s12072-024-10709-y

Chicago

Zhang, Chi, Yiqi Liu, Lin Wang, Xueen Liu, Cuiying Chen, Junli Zhang, Chao Zhang, et al. 2024. “Dose–response Relationship between Serum N-Glycan Markers and Liver Fibrosis in Chronic Hepatitis B.” Hepatology International 18 (5): 1434–47. doi:10.1007/s12072-024-10709-y.